Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation

Terri Montague, Barbara Murphy

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Recent studies have shown the spectrum of dyslipidemia in patients who have chronic kidney disease (CKD) or end-stage renal disease to be different from that of the general population. This article discusses the pathophysiology of dyslipidemia in CKD, dialysis, and renal transplant patients, the therapeutic options, and their association with clinical outcomes. Whenever possible, comparisons are made to outcomes in the general population.

Original languageEnglish
Pages (from-to)223-234
Number of pages12
JournalEndocrinology and Metabolism Clinics of North America
Issue number1
StatePublished - Mar 2009


  • Chronic kidney disease
  • Hemodialysis
  • Hyperlipidemia
  • Renal transplantation
  • Statin


Dive into the research topics of 'Lipid Management in Chronic Kidney Disease, Hemodialysis, and Transplantation'. Together they form a unique fingerprint.

Cite this